TotalMarketCap

10x Genomics

TXGNasdaq United StatesIndustrialsBiotechnology: Laboratory Analytical Instruments

Market cap

$7.563 B

$58.05 -14.03%

Close of 6 Nov 2026

As of 6 Nov 2026, 10x Genomics (TXG) has a market capitalization of $7.56B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$642.8M

#1770 by revenue

Earnings

-$43.5M

Loss-making

Shares outstanding

127,691,329

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Laboratory Analytical Instruments, ranked by market cap

All 22 →
  1. #6Bio-Rad LaboratoriesBIO$9.93B
  2. #7BrukerBRKR$8.84B
  3. #810x GenomicsTXG$7.56B
  4. #9Alamar BiosciencesALMR$1.88B
  5. #10Pacific Biosciences Of CaliforniaPACB$756.9M

What if 10x Genomics were worth as much as…

Open the what-if tool →

Gold $28.2T

$216,721.32

Per share 3,733× higher

Bitcoin $1.53T

$11,726.41

Per share 202× higher

Apple $5.02T

$38,496.72

Per share 663× higher

Or at a round number

$10.0B$20.0B$50.0B$100.0B

Where these numbers come from

Share counts and financials for 10x Genomics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.